Prapela.com Review

Based on checking the website Prapela.com, it presents itself as a specialized platform focusing on breakthrough stimulation therapy for newborns, specifically addressing Neonatal Opioid Withdrawal Syndrome NOWS. The site highlights its Prapela SVS hospital bassinet pad as the first medical device to receive FDA marketing authorization for treating NOWS.

Here’s an overall review summary:

• Purpose: To introduce and provide information about the Prapela SVS hospital bassinet pad, a medical device for treating Neonatal Opioid Withdrawal Syndrome NOWS.
• FDA Authorization: Claims to be the first medical device with FDA marketing authorization for NOWS.
• Target Audience: Likely healthcare professionals, hospitals, and potentially parents seeking information on NOWS treatments.
• Content Focus: Explains NOWS, current assessment and treatment practices non-pharmacological and pharmacological, prevalence, and cost implications.
• Missing Information: Lacks transparent pricing, detailed product specifications, clear purchasing information, customer testimonials, and a comprehensive “About Us” section that builds trust. There is no clear contact method beyond a “Get in Touch” link.
• Ethical Considerations: The product addresses a significant medical issue and appears to be in line with ethical medical practices, particularly given the FDA authorization. The focus on non-pharmacological intervention aligns with a broader ethical approach to patient care.
• Overall Recommendation: While the product itself appears to be a legitimate medical device with FDA authorization, the website lacks critical information that would instill full confidence for a direct purchase or detailed inquiry. Without clear pricing, detailed product specifications, or accessible contact options, it’s difficult for potential buyers to move forward. Therefore, it’s not fully recommended for direct engagement based solely on the website’s current presentation.

The website effectively communicates the problem of NOWS and positions the Prapela SVS bassinet pad as an innovative, FDA-authorized solution.

It provides statistics on the prevalence and cost of NOWS, underlining the need for effective treatments.

However, a significant drawback is the absence of practical information that a potential hospital or healthcare provider would need to evaluate or acquire the device.

0.0 0.0 out of 5 stars (based on 0 reviews) Excellent0% Very good0% Average0% Poor0% Terrible0% There are no reviews yet. Be the first one to write one. Your review Your overall rating Select a Rating5 Stars4 Stars3 Stars2 Stars1 Star Title of your review Your review Your name Your email This review is based on my own experience and is my genuine opinion. ​ Submit Review

Amazon.com: Check Amazon for Prapela.com Review Latest Discussions & Reviews:

Key details like pricing, how to order, or even comprehensive technical specifications are conspicuously absent.

This lack of transparency can be a hurdle for user engagement and conversion.

Here are some alternatives in the ethical medical device and healthcare support space, focusing on non-edible products available in the US:

• GE Healthcare: A global leader in medical technology, diagnostics, and digital solutions. Offers a vast range of medical equipment for hospitals, including neonatal care, imaging, and patient monitoring.
  • Key Features: Comprehensive product portfolio, established reputation, R&D focused, widespread hospital adoption.
  • Price: Varies significantly by product. high-end medical equipment.
  • Pros: Trusted brand, extensive support network, advanced technology.
  • Cons: Primarily enterprise-level solutions, not typically for individual consumers.
• Philips Healthcare: Provides integrated solutions across the health continuum, from healthy living and prevention to diagnosis, treatment, and home care. Strong in patient monitoring, diagnostic imaging, and connected care.
  • Key Features: Innovative technology, focus on integrated solutions, strong global presence, diverse product range.
  • Price: Varies, generally high for professional medical equipment.
  • Pros: Well-regarded, strong research and development, user-friendly designs for healthcare professionals.
  • Cons: Similar to GE Healthcare, mostly for institutional buyers.
• Medtronic: A global leader in medical technology, services, and solutions. Known for a broad range of products, including cardiac and vascular, restorative therapies, and diabetes. While not directly focused on NOWS bassinets, they are a major player in neonatal monitoring and surgical tools.
  • Key Features: Wide range of therapeutic areas, cutting-edge technology, strong clinical evidence.
  • Price: Varies widely, professional medical equipment.
  • Pros: Industry giant, diverse solutions, significant R&D investment.
  • Cons: Primarily serves hospitals and clinics. not a direct alternative for a specific bassinet pad.
• Hill-Rom a Baxter company: Specializes in medical technology, including hospital beds, patient handling equipment, and surgical solutions. Their infant warmers and incubators are relevant for neonatal care environments.
  • Key Features: Focus on patient mobility and safety, integrated hospital solutions, broad range of beds and patient support systems.
  • Price: Enterprise-level pricing.
  • Pros: High-quality, durable equipment, recognized in hospital settings.
  • Cons: Not directly a NOWS-specific device, but provides foundational equipment for neonatal units.
• Zoll Medical: Specializes in resuscitation and acute critical care technologies, including defibrillators, ventilators, and patient monitoring. While not directly a bassinet, their monitoring solutions are crucial in neonatal intensive care.
  • Key Features: Focus on life-saving technology, robust and reliable equipment, comprehensive monitoring.
  • Price: Varies significantly by product.
  • Pros: Leaders in emergency and critical care, highly reliable.
  • Cons: Specialized niche, not a direct competitor for a bassinet.
• Stryker: Offers a diverse range of medical technologies, including orthopaedics, medical and surgical, and neurotechnology and spine. While not a direct match for NOWS, they provide hospital equipment like beds and stretchers used in various medical settings.
  • Key Features: Innovation in surgical and medical equipment, strong market presence, focus on improving patient outcomes.
  • Price: High-end professional equipment.
  • Pros: Reputable brand, high-quality products, broad portfolio.
  • Cons: Not specialized in neonatal withdrawal therapy specifically.
• Dräger: A leading international company in the fields of medical and safety technology. They provide a range of neonatal care products, including incubators, warmers, and ventilation systems.
  • Key Features: Specialization in critical care and neonatal products, high safety standards, advanced technology.
  • Price: Professional medical equipment pricing.
  • Pros: Well-established in critical care, focus on patient safety, high-quality German engineering.
  • Cons: Primarily for hospitals and healthcare institutions, not consumer-focused.

Find detailed reviews on Trustpilot, Reddit, and BBB.org, for software products you can also check Producthunt.

IMPORTANT: We have not personally tested this company’s services. This review is based solely on information provided by the company on their website. For independent, verified user experiences, please refer to trusted sources such as Trustpilot, Reddit, and BBB.org.

Prapela.com Review & First Look

When you land on Prapela.com, the immediate impression is one of professionalism and a clear mission: addressing Neonatal Opioid Withdrawal Syndrome NOWS. The site prominently features its “Breakthrough stimulation therapy for newborns” and highlights the Prapela SVS hospital bassinet pad.

This is a significant piece of information, as it immediately signals that the product is geared towards a serious medical condition.

The homepage quickly delves into the problem of NOWS, explaining its causes, symptoms like hyperirritability, sweating, irregular heart and breathing rates, fever, vomiting, and diarrhea, and the impact of prenatal opioid exposure POE.

The website emphasizes that the Prapela SVS hospital bassinet pad is the “first and only medical device to receive authorization from the Food and Drug Administration to treat newborns exposed to opioids before birth.” This FDA De Novo authorization, granted on April 4, 2025, is a major credibility booster.

For a medical device, regulatory approval from a body like the FDA is paramount, signifying that the product has undergone rigorous testing and meets specific safety and efficacy standards. Smartmugco.com Review

This immediately sets a baseline of trustworthiness for the device itself.

However, from an e-commerce or user-engagement perspective, the website’s initial presentation, while informative about the medical context, lacks direct calls to action for potential buyers or clear pathways to acquire more in-depth product information.

There’s no immediate “Shop Now” or “Request a Quote” visible on the main page, which can be a point of friction for interested parties.

Initial Impressions of Design and Navigation

The design of Prapela.com is clean and professional, utilizing a straightforward layout that prioritizes readability.

The color scheme is calming, predominantly blues and whites, which aligns with a medical context. Gesturecontrolcar.com Review

Navigation is minimal, primarily presenting information about NOWS, current practices, prevalence, and cost.

While this keeps the user focused on the core message, it also limits deeper exploration.

Key sections are logically grouped, and the language used is professional and medically accurate.

However, the lack of a clear navigation menu to explore different product models if any exist, support resources, or an in-depth “About Us” section can make the site feel less comprehensive than expected for a medical device company.

Credibility and Transparency Indicators

The most significant credibility indicator on Prapela.com is the explicit mention of FDA De Novo authorization for the Prapela SVS hospital bassinet pad. Areawala.com Review

This is a crucial detail for any medical device and provides a strong foundation of trust.

The website also cites the American Academy of Pediatrics AAP regarding non-pharmacological interventions as first-line treatment for NOWS, which further reinforces its medical legitimacy.

It discusses assessment methods like the Finnegan Neonatal Abstinence Scoring System and the Eat, Sleep & Console ESC approach, demonstrating an understanding of current clinical practices.

However, transparency is a double-edged sword here.

While the medical information is transparent and well-presented, the operational transparency is lacking. Mystorytee.com Review

There’s no clear “About Us” page detailing the company’s history, leadership, or mission beyond the product itself.

Contact information is limited to a “Get in Touch” section at the bottom, without a visible phone number or direct email address.

This lack of robust contact options and company background can raise questions for potential partners or large institutional buyers who require extensive due diligence.

Understanding Neonatal Opioid Withdrawal Syndrome NOWS

Neonatal Opioid Withdrawal Syndrome NOWS is a severe condition affecting newborns exposed to opioids in utero.

The website accurately describes the heartbreaking reality of NOWS, noting it as “one of the more sorrowful consequences of our opioid crisis.” This condition arises from prenatal opioid exposure POE, leading to a range of postnatal withdrawal symptoms in affected infants. Thepluglist.com Review

Understanding NOWS is critical, as it requires specialized care and can have significant implications for a newborn’s early development and the healthcare system at large.

Symptoms and Impact on Newborns

Newborns with NOWS experience a distressing array of symptoms, as highlighted on Prapela.com:

• Hyperirritability: Infants may be excessively irritable, crying inconsolably.
• Sweating: Abnormal sweating can occur.
• Irregular Heart and Breathing Rates: Fluctuations in vital signs are common.
• Fever: Elevated body temperature.
• Vomiting and Diarrhea: Gastrointestinal distress.
• Tremors: Involuntary muscle movements.
• Increased Muscle Tone: Rigidity in muscles.
• Fragmented Sleep: Difficulty sleeping for sustained periods.

These symptoms indicate a systemic impact of opioid withdrawal, requiring vigilant monitoring and management.

The hyperirritability and fragmented sleep, in particular, underscore the need for interventions that promote comfort and rest, which is where the Prapela SVS bassinet pad aims to provide support through stimulation therapy.

The impact on newborns extends beyond immediate symptoms, often necessitating extended hospital stays and specialized care, which can be emotionally and financially taxing for families and the healthcare system. Hellolife.net Review

Current Assessment and Treatment Practices

The website provides a concise overview of current practices for assessing and treating NOWS, which aligns with recognized medical guidelines.

Assessment Methods:

• Finnegan Neonatal Abstinence Scoring System FNASS: Historically, FNASS was the most widely used method to diagnose NOWS. This system involves scoring various withdrawal symptoms based on their severity.
• Eat, Sleep & Console ESC: Since 2019, the ESC approach has gained significant acceptance in the medical community. This method focuses on a newborn’s functional abilities:
  • Eat: Ability to consume an expected amount based on gestational age.
  • Sleep: Ability to sleep after eating for at least an hour.
  • Console: Ability to be consoled within 10 minutes of soothing.

Prapela.com notes a retrospective study involving 2,375 newborns with POE, which revealed “no differences in pharmacotherapy, length of treatment, and length of stay between the two assessment methods.” This suggests that while ESC is gaining traction, both methods are considered effective for guiding clinical decisions.

Treatment Approaches:

• Non-pharmacological Treatment: The American Academy of Pediatrics AAP designates non-pharmacological interventions as the first-line treatment for NOWS. These supportive care methods include:
  • Removal of environmental stimuli
  • Rooming-in
  • Swaddling and positioning
  • Rocking and swaying
  • Frequent feedings
  • Skin-to-skin contact/kangaroo care

Prapela.com highlights that these interventions “require intensive caregiver interaction, which is often not sustainable.” This implicitly positions the Prapela SVS pad as a complementary or supplementary tool to these non-pharmacological methods, aiming to provide consistent support without constant direct caregiver interaction. Berthold.com Review

• Pharmacological Treatment: For severe withdrawal symptoms, pharmacological treatment may be necessary. The AAP supports the use of an opioid as a first-line pharmacotherapy treatment to manage these severe symptoms. The website states that “an estimated 33% to 80% of newborns treated for NOWS receive medication to manage severe withdrawal symptoms.” This statistic underscores the severity of some NOWS cases and the challenges in managing them solely through non-pharmacological means, further emphasizing the potential role of devices like the Prapela SVS pad in reducing the need for medication.

Prevalence and Economic Burden of NOWS

The statistics presented on Prapela.com regarding the prevalence and cost of NOWS paint a sobering picture of the opioid crisis’s impact on newborns in the United States.

These figures underscore the critical need for effective, scalable interventions.

• Increased Maternal Opioid Use: From 2010 to 2017, maternal use of opioids increased by a staggering 130%. This sharp rise directly correlates with the increase in NOWS cases.
• Births with POE: As a result of increased maternal opioid use, 8.2 out of every 1000 babies born in the United States during that period had prenatal opioid exposure POE. This translates to tens of thousands of newborns annually affected by this crisis.
• Development of Withdrawal Symptoms: A significant proportion of these exposed newborns develop withdrawal symptoms, with estimates ranging from 55% to 95% of newborns with POE developing NOWS. This high percentage indicates that exposure often leads to clinical manifestations requiring intervention.
• Length of Hospital Stay LOS: For babies diagnosed with NOWS, the overall mean length of hospital stay is 9 to 16 days. This extended hospitalization is a major factor in the economic burden and resource strain on healthcare facilities.
• Annual Hospital Charges: The economic impact is substantial, with annual hospital charges for NOWS in the United States reported to exceed $1.5 billion annually. A concerning two-thirds of these charges are billed to Medicaid, highlighting the significant public health expenditure associated with managing this condition. These figures emphasize the potential cost savings and resource optimization that effective non-pharmacological or device-based interventions like the Prapela SVS pad could offer by reducing the need for extended hospitalizations and pharmacological treatments.

Prapela.com Features: The SVS Hospital Bassinet Pad

The core offering of Prapela.com is the Prapela SVS hospital bassinet pad.

While the website doesn’t offer a traditional “features” list like a consumer product, it does articulate the key aspects that make this device noteworthy, primarily its intended function and regulatory approval.

The focus is on its role as a “breakthrough stimulation therapy” designed to support newborns experiencing NOWS. Duxburyscommercial.com Review

How the SVS Bassinet Pad Works

The website describes the Prapela SVS bassinet pad as providing “breakthrough stimulation therapy.” While it doesn’t go into granular detail about the precise mechanism of action e.g., specific frequencies, patterns of vibration, the implication is that the controlled, gentle stimulation helps to soothe newborns and manage their withdrawal symptoms.

This aligns with the concept of non-pharmacological interventions, which aim to reduce hyperirritability and promote rest without medication.

The idea is that consistent, therapeutic stimulation can mimic aspects of the intrauterine environment or provide a calming sensory input that helps regulate the infant’s physiological responses.

The benefit lies in providing this support continuously, which, as the site notes, can be challenging with human caregiver interaction alone due to its intensive nature.

FDA Authorization and Significance

The most significant feature, and arguably the cornerstone of Prapela’s credibility, is its FDA De Novo authorization. The website proudly states that on April 4, 2025, the FDA granted De Novo authorization to the Prapela SVS hospital bassinet pad, making it “the first medical device with FDA marketing authorization to treat NOWS.” Zingpcs.com Review

What does FDA De Novo authorization mean?

• Novel Device: De Novo classification is for novel, low- to moderate-risk devices for which no legally marketed predicate device exists. This means the Prapela SVS bassinet pad is breaking new ground in its specific application.
• Rigorous Review: To receive De Novo authorization, a device must undergo a rigorous review process by the FDA to demonstrate reasonable assurance of safety and effectiveness for its intended use. This involves submitting clinical data, engineering specifications, and quality system information.
• Marketing Authorization: This authorization allows the company to legally market and sell the device in the United States. It’s not just a registration. it’s a stamp of approval from the highest regulatory body for medical devices in the US.

The significance of this authorization cannot be overstated for a medical device aimed at a vulnerable population like newborns.

It assures healthcare providers and parents that the device has met stringent federal standards and has been clinically evaluated for its stated purpose.

This distinguishes the Prapela SVS pad from unregulated devices or therapies and positions it as a legitimate, evidence-backed tool in the fight against NOWS.

For hospitals considering adoption, FDA authorization is often a prerequisite. 500talents.co Review

Prapela.com Pros & Cons

A thorough review of Prapela.com, based solely on the provided homepage text, reveals several strengths and weaknesses.

Understanding these can help potential users, particularly healthcare institutions, assess the website’s utility and the product’s perceived value.

Advantages of Prapela.com’s Presentation

• Clear Problem Statement: The website excels at articulating the problem of Neonatal Opioid Withdrawal Syndrome NOWS. It clearly defines the condition, its symptoms, and the impact of prenatal opioid exposure, making it easy for visitors to grasp the challenge the product aims to solve.
• Strong Credibility with FDA Authorization: The explicit mention of FDA De Novo authorization for the Prapela SVS bassinet pad is a major advantage. This regulatory approval is a powerful indicator of safety and effectiveness, instilling confidence in the medical community.
• Relevant Medical Context and Statistics: Prapela.com provides valuable statistics on the prevalence of NOWS, the increase in maternal opioid use, and the significant financial burden over $1.5 billion annually in hospital charges. This data grounds the product in a real-world, pressing healthcare need.
• Emphasis on Non-Pharmacological Approach: The site highlights the American Academy of Pediatrics’ recommendation for non-pharmacological interventions as first-line treatment. By positioning the SVS pad within this framework, Prapela aligns itself with established, patient-centered care practices, which is ethically commendable.
• Professional and Clean Design: The website’s design is straightforward, clean, and professional. It’s easy to read and navigate, ensuring that the critical information is accessible without unnecessary clutter.

Disadvantages and Areas for Improvement

• Lack of Pricing Information: This is perhaps the most significant drawback. There is absolutely no mention of the cost of the Prapela SVS hospital bassinet pad. For hospitals and healthcare systems, budget and cost-effectiveness are paramount. Without pricing, it’s difficult for potential buyers to even begin an evaluation.
• Limited Product Specifications: Beyond its function as a “stimulation therapy,” detailed technical specifications of the bassinet pad are absent. What are its dimensions? Power requirements? Maintenance needs? Any specific features like adjustable settings or data logging? This information is crucial for medical equipment procurement.
• Absence of Purchasing/Ordering Process: The website doesn’t outline how a hospital or healthcare provider would go about purchasing or even inquiring about the device. There are no “Request a Quote,” “How to Order,” or “Sales Contact” sections clearly visible. The “Get in Touch” link is vague.
• Minimal “About Us” Information: While the focus is on the product, a comprehensive “About Us” section that details the company’s mission, history, team, or scientific advisors would significantly enhance trustworthiness and build rapport with potential partners.
• No Customer Testimonials or Case Studies: For a medical device, especially one with FDA authorization, showcasing success stories, pilot program results, or testimonials from hospitals already using the Prapela SVS pad would be incredibly powerful in demonstrating real-world efficacy and value.
• Limited Contact Options: The only explicit call to action for contact is a generic “Get in Touch” link. A direct phone number, specific email addresses for sales or support, or a contact form with specific fields would be more helpful for serious inquiries.
• No FAQ Section on homepage: While this review includes one, the actual Prapela.com homepage does not present a comprehensive FAQ, which could proactively answer common questions about the product, its use, or procurement.

Prapela.com Alternatives

• GE Healthcare
  • Description: A multinational conglomerate producing advanced medical imaging, monitoring, and diagnostic technologies, including incubators, warmers, and ventilators for neonatal intensive care units NICUs. They are a cornerstone of hospital equipment.
  • Key Features: Comprehensive suite of NICU equipment, advanced patient monitoring, established global support and service, high reliability.
  • Pros: Industry leader, highly trusted, extensive R&D, integrated solutions.
  • Cons: High initial investment, complex systems requiring specialized training.
• Philips Healthcare
  • Description: Offers a wide array of healthcare technology solutions, including patient monitoring systems, therapeutic care devices, and informatics solutions essential for NICUs. Their focus on connected care can integrate various aspects of patient management.
  • Key Features: Advanced patient vital sign monitoring, respiratory support, broad portfolio covering critical care, user-friendly interfaces.
  • Pros: Strong reputation, innovative solutions, focus on clinician workflow, global presence.
  • Cons: Enterprise-level pricing, integration can be complex with existing hospital systems.
• Medtronic
  • Description: While primarily known for therapeutic devices e.g., cardiac, diabetes, Medtronic also provides critical care solutions. In the context of neonatal care, their monitoring and surgical instruments can be vital components within a NICU environment, supporting overall patient management.
  • Key Features: Broad range of medical devices, strong clinical research backing, focus on improving patient outcomes.
  • Pros: Leading medical device company, high quality, innovative.
  • Cons: Not a direct competitor in NOWS-specific therapy, more general critical care support.
• Hill-Rom a Baxter company
  • Description: Specializes in patient support systems, including hospital beds, patient handling, and infant care solutions like warmers and incubators. Their products focus on patient comfort, safety, and caregiver efficiency in acute care settings.
  • Key Features: Designed for patient comfort and safety, durable hospital-grade equipment, integrated solutions for patient mobility.
  • Pros: Renowned for hospital equipment, focus on patient and caregiver needs, robust products.
  • Cons: Products are foundational, not specific therapeutic devices like the Prapela pad.
• Dräger
  • Description: A leader in medical and safety technology, Dräger provides specialized solutions for neonatal care, including incubators, infant warmers, and ventilation systems. They are known for high-quality, precise equipment crucial for vulnerable newborns.
  • Key Features: Focus on respiratory and incubation technology, high safety standards, designed for critical care environments.
  • Pros: Specialization in neonatal life support, reliable, advanced technology.
  • Cons: High-end, specialized equipment, not a direct treatment for NOWS.
• Fisher & Paykel Healthcare
  • Description: A global leader in respiratory humidification and sleep apnea devices. Their products are critical for respiratory support in neonatal intensive care, ensuring optimal breathing conditions for fragile infants.
  • Key Features: Specialization in respiratory care, humidification systems, patient interfaces for ventilation.
  • Pros: Expertise in respiratory support, high-quality products for critical care.
  • Cons: Niche focus on respiratory, not general neonatal care equipment.
• Invacare
  • Description: While more known for home care and long-term care products, Invacare offers a range of patient care equipment like specialized beds and patient lifts that could be adapted or considered in broader hospital settings.
  • Key Features: Focus on patient mobility and comfort, durable medical equipment, various support solutions.
  • Pros: Broad product range, often more cost-effective for certain applications.
  • Cons: Not specialized in neonatal critical care. more general patient support.

How to Inquire About Prapela.com Products

Based on the Prapela.com homepage, the options for inquiring about their products, specifically the Prapela SVS hospital bassinet pad, are quite limited.

Unlike many e-commerce sites or even B2B medical equipment websites that offer clear sales contact forms, direct phone numbers, or “Request a Quote” buttons, Prapela.com steers inquiries towards a single, less specific pathway. Bitfxt.com Review

Contacting Prapela.com for Sales or Information

The primary, and seemingly only, method for contacting Prapela.com directly from their homepage is through the “Get in Touch” link located at the bottom of the page. Clicking this link is expected to lead to a contact form or provide contact details. However, without actually clicking through, the homepage itself does not display a direct email address, a phone number, or a physical address. This minimal contact information can be a barrier for hospitals or healthcare organizations that require immediate assistance, have complex procurement processes, or prefer direct communication channels for high-value medical equipment. Typically, for medical devices, a dedicated sales team contact or a clear inquiry process for institutional buyers is expected. The current setup suggests that potential buyers must initiate contact via a generic form, which may delay the sales cycle and provide less immediate support than desired.

Missing Information for Procurement Teams

For hospital procurement teams, the current website falls short in providing essential information upfront.

A robust medical device website for institutional buyers usually includes:

• Dedicated Sales Contact: A specific phone number or email for sales inquiries.
• Product Catalogs/Brochures: Downloadable PDFs with detailed specifications, clinical data, and usage guidelines.
• Request a Quote Form: A structured form that allows institutions to specify their needs and receive a tailored quotation.
• Clinical Support Information: Details on training, implementation support, and ongoing technical assistance.
• Financing Options: Information on leasing, purchasing programs, or payment terms.
• Case Studies/Pilot Programs: Evidence of successful implementation in other hospitals.

The absence of these elements means that procurement teams would need to rely solely on the “Get in Touch” function, potentially leading to a longer and less efficient information gathering process.

This lack of detailed, proactive information can be a significant hurdle for widespread adoption in a competitive medical device market. Sarona.com Review

Prapela.com Pricing

One of the most significant pieces of missing information on Prapela.com’s homepage is any mention of pricing for the Prapela SVS hospital bassinet pad.

This is a considerable omission, especially for a medical device aimed at institutional buyers like hospitals and healthcare systems.

Lack of Publicly Available Pricing

The entire Prapela.com homepage, as provided, contains no information about the cost, pricing models, or even a range for the Prapela SVS hospital bassinet pad. This means:

• No upfront cost disclosure: Hospitals cannot gauge the financial investment required without direct contact.
• No indication of purchase vs. lease options: It’s unclear if the device is available for outright purchase, lease, or perhaps a subscription model for the stimulation therapy.
• No volume discounts or package deals: For larger healthcare networks or those looking to outfit multiple NICU beds, understanding potential bulk pricing is crucial.

In the medical device industry, it’s common for high-value equipment not to have explicit pricing listed on public websites, as costs can vary based on volume, customization, support agreements, and regional differences.

However, typically there would be a clear pathway to “Request a Quote” or contact a sales representative for pricing information. Hourly.io Review

The generic “Get in Touch” button is the only hint for how to obtain this critical detail, which places the burden on the interested party to initiate contact without any preliminary financial context.

Impact on Hospital Budgeting and Procurement

The absence of pricing directly impacts a hospital’s ability to budget and proceed with procurement.

• Delayed Decision-Making: Without an estimated cost, hospital finance departments cannot allocate funds, and procurement teams cannot compare the Prapela SVS pad against other potential investments or existing treatment protocols on a cost-benefit basis. This can significantly slow down the decision-making process.
• Increased Inquiry Overhead: Every interested hospital has to go through an initial inquiry to simply get a price, creating additional administrative overhead for both Prapela and the potential buyer.
• Perception of Secrecy: While standard for some high-value medical equipment, the complete lack of any pricing context might be perceived as a lack of transparency, especially for smaller hospitals or clinics attempting an initial assessment.
• Comparison Difficulties: Hospitals often compare multiple solutions based on efficacy, features, and cost. Without the pricing, the cost component of this critical evaluation is entirely absent, making it harder to build a comprehensive case for adoption.

To streamline the sales process for institutional buyers, Prapela.com would benefit significantly from adding a dedicated “Request a Quote” feature or providing general information about their sales process, even if exact prices are not publicly displayed.

FAQ

What is Prapela.com?

Prapela.com is the official website for Prapela, a company that has developed the Prapela SVS hospital bassinet pad, a medical device authorized by the FDA to treat newborns exposed to opioids before birth, specifically for Neonatal Opioid Withdrawal Syndrome NOWS.

What is the Prapela SVS hospital bassinet pad?

The Prapela SVS hospital bassinet pad is a medical device designed to provide stimulation therapy for newborns experiencing Neonatal Opioid Withdrawal Syndrome NOWS, aiming to soothe and manage their withdrawal symptoms without constant caregiver interaction. Manninglawapc.com Review

Is the Prapela SVS bassinet pad FDA authorized?

Yes, the Prapela SVS hospital bassinet pad received De Novo authorization from the Food and Drug Administration FDA on April 4, 2025, making it the first medical device with FDA marketing authorization to treat NOWS.

What is Neonatal Opioid Withdrawal Syndrome NOWS?

NOWS is a condition in newborns resulting from prenatal opioid exposure POE, characterized by symptoms like hyperirritability, sweating, irregular heart and breathing rates, fever, vomiting, diarrhea, tremors, and fragmented sleep.

How common is NOWS in the United States?

From 2010 to 2017, maternal opioid use increased by 130%, resulting in 8.2 out of every 1000 babies born in the United States with prenatal opioid exposure, with 55% to 95% of these newborns developing NOWS.

What are the main symptoms of NOWS?

Common symptoms of NOWS include excessive crying, fragmented sleep, tremors, increased muscle tone, gastrointestinal dysfunction vomiting, diarrhea, hyperirritability, sweating, irregular heart and breathing rates, and fever.

How is NOWS typically assessed?

Historically, the Finnegan Neonatal Abstinence Scoring System FNASS was used. Tutree.com Review

More recently, the Eat, Sleep & Console ESC assessment has gained acceptance, focusing on a newborn’s ability to eat, sleep, and be consoled.

What are the first-line treatments for NOWS?

The American Academy of Pediatrics AAP recommends non-pharmacological interventions as first-line treatment for NOWS, including swaddling, rooming-in, skin-to-skin care, rocking, frequent feedings, and removal of environmental stimuli.

Does Prapela.com provide pricing for the SVS bassinet pad?

No, the Prapela.com website does not provide any public pricing information for the Prapela SVS hospital bassinet pad.

Potential buyers need to use the “Get in Touch” feature to inquire about costs.

How can I contact Prapela.com for more information?

You can contact Prapela.com by clicking the “Get in Touch” link typically found at the bottom of their homepage, which is expected to lead to a contact form or further contact details.

Is Prapela.com intended for individual consumers or hospitals?

Based on the content, particularly the mention of “hospital bassinet pad” and medical device authorization, Prapela.com is primarily intended for healthcare professionals and institutions like hospitals.

Are there clinical studies supporting the Prapela SVS bassinet pad?

While the website mentions FDA authorization, which implies underlying clinical data for safety and efficacy, it does not explicitly link to or summarize specific clinical studies or research papers supporting the Prapela SVS bassinet pad on its homepage.

Does the Prapela SVS bassinet pad replace other NOWS treatments?

The website indicates that traditional non-pharmacological treatments “require intensive caregiver interaction, which is often not sustainable.” This suggests the Prapela SVS pad is designed to complement or enhance existing non-pharmacological methods rather than replace them entirely.

What is the average length of hospital stay for NOWS babies?

The overall mean length of hospital stay LOS for babies with NOWS ranges from 9 to 16 days, contributing significantly to healthcare costs.

What are the annual costs associated with NOWS in the US?

Annual hospital charges for NOWS in the United States have been reported to exceed $1.5 billion, with more than two-thirds of these charges billed to Medicaid.

Does Prapela.com offer a free trial?

The provided homepage text does not mention any information about a free trial for the Prapela SVS hospital bassinet pad.

Can I cancel a Prapela.com subscription?

Since the website does not mention any subscription model for the Prapela SVS bassinet pad, there is no information available on how to cancel a subscription. It appears to be a direct medical device purchase.

Are there any other products offered by Prapela.com?

Based solely on the provided homepage text, the Prapela SVS hospital bassinet pad is the only product explicitly mentioned and highlighted by Prapela.com.

What are some ethical alternatives for neonatal care equipment?

Ethical alternatives for general neonatal care equipment include products from established medical device companies such as GE Healthcare, Philips Healthcare, Medtronic, Hill-Rom a Baxter company, and Dräger. These companies offer various products like incubators, warmers, and patient monitoring systems.

Does Prapela.com offer customer testimonials or case studies?

No, the Prapela.com homepage, based on the provided text, does not feature customer testimonials, case studies, or success stories from hospitals that have implemented the Prapela SVS bassinet pad.